BioCentury
ARTICLE | Clinical News

IL-12: Hopes to restart clinical trials this fall. A Phase II study in advanced kidney cancer was suspended in June after the hospitalization of 10 patients and

August 21, 1995 7:00 AM UTC

Genetics Institute Inc.(GENIZ), Cambridge, Mass. Product: IL-12 Indication: Cancer and HIV Status: Hopes to restart clinical trials this fall. A Phase II study in advanced kidney cancer was suspended ...